This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Recombinant vaccines in 2022: a perspective from the cell factory
Microbial Cell Factories Open Access 05 October 2022
-
Plant-based solutions for veterinary immunotherapeutics and prophylactics
Veterinary Research Open Access 31 December 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
News In Brief. Nat Biotechnol 24, 233–234 (2006). https://doi.org/10.1038/nbt0306-233
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0306-233
This article is cited by
-
Plant-made pharmaceuticals: exploring studies for the production of recombinant protein in plants and assessing challenges ahead
Plant Biotechnology Reports (2023)
-
Recombinant vaccines in 2022: a perspective from the cell factory
Microbial Cell Factories (2022)
-
Seed-Based System for Cost-Effective Production of Vaccine Against Chronic Respiratory Disease in Chickens
Molecular Biotechnology (2022)
-
Current state-of-the-art in the use of plants for the production of recombinant vaccines against infectious bursal disease virus
Applied Microbiology and Biotechnology (2020)
-
Plant-based solutions for veterinary immunotherapeutics and prophylactics
Veterinary Research (2014)
